Abstract Purpose: To synthesize silver nanoparticles using rhizome extract (RE) of E. wallichii as a bioreductant and surfactant.
INTRODUCTION
Nanobiotechnology is an interdisciplinary science with the application to the biological systems to manufacture new biochemical system. The transformed nanobiosystems exhibit completely new properties like morphology, density, diffusion rate, catalytic potential and size distribution [1] . Fabrication of nanoparticles via green route enhances physiological potential, much economical and ecofriendly compared to chemical and physical methods which requires high energy, use toxic and expensive chemicals [2] .
The modulation of metals into their nanoscale structures by phytometabolites is of vital importance for the development of nanomedicine.
Nanoparticles derived from metallic silver, made notable comeback as a potent antimicrobial, antimalarial and as antiangiogenic agent.
Thus, AgNPs have diverse applications in modern health system like silver coated medicinal devices, dressings, nanogels and nano-lotions [3] . Plant extracts have the capability to reduce metals ions and to synthesize biogenic nanoparticles, improve their monodispersion and modulate their shapes and sizes. Different transition metals like Au, Mn, Zn, Ti, Cu and Ag have been used for the synthesis of nanoparticles but silver was proven to be most effective against bacteria, viruses and other pathogenic microbes [4] . Green and biogenic synthesis of nanoparticles is highly advantageous over both physical and chemical methods for its low cost and eco-friendly method as it avoids the use of high temperature, energy, pressure and toxic hazardous chemicals. Phytometabolites provide a better platform for biogenic nanoparticles as they are providing natural capping agents free from toxic chemicals [5] .
Euphorbia wallichii is a himalayan herb, used in tibet as folkloric remedy for curing furuncle, exanthema, cutaneous anthrax and other skin disorders. Stem latex is using for healing external wounds while whole plant is highly laxative and causes severe diarrhea [6, 7] .
EXPERIMENTAL
The plant specimen was collected from Abbottabad Pakistan and a voucher specimen (no. Bot.20078 PUP) was submitted to the herbarium of Department of Botany, University of Peshawar, Pakistan.
The shade dried and powdered rhizome was subjected to successive extraction by 70 % ethanol and filtrate was evaporated with rotary evaporator at 50±3 o C.
Rhizome extract of E. wallichii (RE) was screened for different phytomatabolites like reducing sugar, alkaloids, saponins, glycosides, proteins, phenols, flavonoids, phytosterols and tannins as per standard procedures [8] .
Biogenic synthesis of AgNPs
Aqueous solution of RE (200 µg/mL) was mixed with 1 mM AgNO 3 (Aqu) in different ratios (1:5, 1:10, 1:15, 1:20, 1:25, 1:30 and 1:35 v/v) on magnetic stirrer at 35 ± 3 °C till the color of solution turned yellow brown. Optimization of AgNPs was brought by measuring UV-Visible spectrum against ethanol in deionized water as a blank with a resolution of 1 nm between the wavelength ranges of 300 to 800 nm. Dried powder of RE-AgNPs was mixed with KBr, pressed by hydraulic Pellet Press and subjected to FT-IR spectroscopy using "PerkinElmer spectrometer FT-IR Spectrum One". XRD pattern was analyzed using JEOL JDX 3532 X-ray diffractometer. The dried AgNPs was coated on a carbon tape, subjected to gold coating and analyzed for morphological features through SEM. Size distribution was analyzed through dynamic light scattering (DLS) technique using Malven Zetasizer. For EDX, powdered AgNPs mass was subjected to elemental mapping using the Oxford Inca 200 SEM instrument equipped with a Thermo EDX attachment.
Antileishmanial bioassay
In vitro anti-leishmanial activity was performed against Leishmania tropica (KWH 23 
Assessment of analgesic activity
In vivo analgesic potency of RE and RE-AgNPs were determined using Swiss albino mice. The animals were divided into eight groups (n = 6), i.e. group I; received saline at 10 ml/kg bw (i.p); Group II; diclofenac sodium at 10 mg/kg bw (i.p); groups III, IV & V; received 50, 100 and 200 mg/kg bw of RE, respectively (i.p) and groups VI, VII and VIII received 50, 100 and 200 mg/kg bw of RE-AgNPs respectively (i.p).
The paw flicking and jumping response of animals at 55 ± 2 o C was investigated using eddy's analgesiometer, after 30, 60 and 90 min of drugs administration [9] . The experimental animals were dealt as per protocols of international guidelines for animal studies during the entire period of study [10] .
Evaluation of antispasmodic activity
The overnight fasted mice were divided into eight groups (six mice in each) i.e. group I; received saline at 10 ml/kg bw, (p.o), group II; received atropine sulphate at 10 mg/kg bw, (p.o), Group III, IV and V; respectively received doses of 50, 100 and 200 mg/kg bw of RE (p.o) and Group VI, VII & VIII received 50, 100 & 200 mg/kg bw of RE-AgNPs respectively (p.o). The experimental animals were dealt as per protocols of international guidelines for animal studies during the entire period of study [10] . 0.2 mL of activated charcoal was given to all animals after 15 min of doses administration. Animals were sacrificed by cervical dislocation after 30 min of charcoal treatment, dissected and the intestine was cut down from pyloric to caecum. The distance travelled by the charcoal relative to the total intestinal length was measured as percent propulsion using equation I.
Propulsion (%) = CT/TL × 100 …….. (1) where CT = charcoal meal traveled in small intestine and TL = Total intestinal (small) length.
Determination of antioxidant potential
RE and RE-AgNPs were tested for free radical scavenging assay (antioxidant potential) using 2, 2-diphenyl-1-picrylhydrazyl (DPPH). Different doses (10, 20, 40, 60, 80 and 100 µg/mL) of RE and RE-AgNPs were mixed with 0.I mM DPPH. The reaction mixtures were tested for optical density (OD) at 517 nm after 30, 60 and 90 min of incubation. Untreated DPPH was run as control condition while ascorbic acid treated DPPH was run as a standard antioxidant drug. Antioxidant efficiency (E) was determined as in Eq 2.
E (%) = (Ab -At/Ab}100 …………. (2) where Ab, At are the absorbance of blank and test, respectively samples.
Evaluation of antibacterial activity
Sterile petri plates filled with Mueller-Hinton agar were autoclaved. Freshly prepared diluted culture of tested bacterial strains was swabbed on Mueller-Hinton agar plates. Wells of 6mm diameters were bored, filled with 2 mg/ml of each streptomycin RE and RE-AgNPs, incubated at 30 °C for 24 h and evaluated for zone of inhibition (mm).
Statistical analysis
Data obtained for characterization was plotted using Origin Pro.9.1. The effective concentration for antioxidant potential was determined using Probit analysis in Biostat plus. ANOVA was used for the comparison of mean effect followed by LSD as post-hoc test using SPSS. Antimicrobial, Analgesic and antispasmodic efficacy were expressed as mean ± SEM using GraphPad Prism 7.
RESULTS
The phytochemical investigation of RE showed the presence of alkaloids, glycosides, reducing sugars, phenols, proteins, flavonoids, saponins, phytosterols and tannins (Table 1) ANOVA results revealed significant (p < 0.05) growth inhibition of all tested bacterial strains. RE-AgNPs was more potent in inhibiting the growth of all tested bacterial strains than RE alone (Figure 7 ). E. coli was found to be more susceptible to AgNPs than streptomycin, while P. aeruginosa was found more resistant to all treatments.
Both RE and RE-AgNPs were tested for their in vitro antileishmanial efficacy against Leishmania tropica. RE exhibited dose dependent mortality of 37, 53 and 62 % at 10, 50 and 100 µg/mL doses respectively with LD 50 of 34.73 µg/mL. REAgNPs revealed pronounced anti-leishmanial property, exhibiting 28, 60 and 82 % lethality at 10, 50 and 100 µg/mL respectively with LD 50 of 27.30 µg/mL (Figure 8 ).
Mice treated with RE at 50, 100 and 200 mg/kg bw, produced 30.51, 39.71 and 78.85 % spasmolytic responses compared to atropine sulphate. Experimental animals treated with REAgNPs, revealed dose dependent spasmolytic action, exhibiting 62.29, 77.54 and 83.21 % antispasmodic efficacy at 50, 100 and 200 mg/kg bw respectively compared to the atropine sulphate ( Figure 9 ). In the paw flick test, pre-oral administration of RE and RE-AgNPs caused significant (p < 0.05) dose related analgesia, though less analgesic than standard diclofenac sodium ( Figure 10 ). RE-AgNPs were more potent than RE probably due to their rapid diffusion as they possess considerably small sizes (1 -100 nm). Antioxidant potential of RE and RE-AgNPs was evaluated using DPPH as a source of free radical. The effective concentrations for 50 % DPPH inhibition (EC 50 ) were 5.84, 5.45 and 3.46 µg/mL for RE-AgNPs, RE and ascorbate respectively. RE at 30 and 60 min was generally more effective than AgNPs. 
DISCUSSION
Phytochemical screening validates the presence of various primary and secondary metabolites. Available literature reveals that aqueous extract of E. wallichii rhizome shows the presence of saponins, steroids, and triterpenoids, while alkaloid was absent. Similarly, ethanol extract of E. thymifolia showed the presence of alkaloids, flavonoids, phenols and phytosterols [11] . Synthesis of AgNPs was primaraly confirmed by change in colour of reaction mixture to dark brown which is due to excitation of electron on the surface (SPR) of the newly synthesized nanoparticles [12] .
Synthesis of AgNPs accomplished by the reduction of Ag + to Ag 0 by phytometabolites, form oligomeric clusters due to agglomeration which lead to the synthesis of colloidal AgNPs. AgNPs shows typical absorption band in visible region due to its characteristic SPR [13] . DLS of REAGNPs showed bimodal size distribution with mean particle size of 30.57 nm which is different from size distribution revealed by SEM of REAgNPs (20 -58 nm) . This difference is due to the fact that electron microscopy considers only the metallic core while DLS includes the ligand shell and determines the hydrodynamic size [14] . EDX spectral analysis of RE-AgNPs shows intense optical absorption approximately at 3 KeV, whereas other less intense peaks for other elements are related to the binding energies of bio-compounds capped the AgNPs [13] .
Metallic nanoparticles target multiple cellular components including cell wall, cell membrane, cytoplasmic organelles and DNA, hence there is least chance for microbe to develop resistance [15] . The antibacterial mechanisms of these nanoparticles include binding of positively charged silver to negatively charged DNA and proteins, thus disrupting cellular metabolic pathways [16, 17] . AgNPs also shown attachments to the bacterial plasma membrane proteins thus disturbing its permeability and respiration, hence making AgNPs, a more potent antimicrobial agents [18] .
Accumulation of nanoparticles at targeted site has seems to be in high concentration than normal drugs which often leads to reduced systemic toxicity. AgNPs has the tendency to impair with glycoprotein 63 and lipophosphoglycan found on the leishmanial parasite surface leads to generate oxidative stresses and inhibit the growth of leishmanial parasite [19] . The GI tract motility is mainly initiated by the local reflexes and is myogenic. The extrinsic nerves of GI tract have limited role in modulating the peristalsis. Opioid delays gastric emptying through acting on GI sphincters hence decrease intestinal transit. The smooth muscles showing mark contraction when exposed to neurotransmitter where acetylcholine released from acetylcholine receptors (parasympathetic nerves) [20] .
Antispasmodics like atropine and dicyclomine are antagonist of muscarinic acetylcholine receptors and RE-AgNPs exhibited promising antispasmodic effect by antagonizing muscarinic acetylcholine receptors. The spasmolytic effect of REAgNPs was more evident than RE due to the provision of large surface area for antagonism. The current results suggest the involvement of µ-opioid receptors mediated by RE and RE-AgNPs resulting in the generation of analgesic response through central system. Non-thermal nociceptive tests are sensitive to κ-agonists opioid while thermal analgesic tests are more sensitive to µ-agonists opioids [21] . The analgesic activity of E. wallichii is attributable to the presence of potent secondary metabolites i.e. alkaloids, flavonoids and saponins known for triggering prostaglandins responsible for peripheral nociceptive perception [22] . The ability of phytometabolites to bleaching DPPH purple color indicating their electron donation tendency [23] .
Plants with adequate phenolic contents have been observed with potent antioxidant properties. The antioxidant potential is correlated to the phenolic contents of the plants which has the redox potential where they act as proton donor [24] . Other phytometabolites like reducing sugars, tannins and proteins present in plant extracts may also be responsible for antioxidant activity [25] . The promising antioxidant potential of E. wallichii is attributed to the presence of reducing biomolecules like phenols, flavonoids, reducing sugars etc. as evident from biochemical tests. RE delivered elevated DPPH scavenging properties than AgNPs, due to the affinity of both DPPH and Ag+ ions for the reducing agents.
CONCLUSION
The findings of this study demonstrate that RE has tremendous reducing potential for silver ions and functionalizes the synthesized AgNPs, Biomemic RE-AgNPs significantly inhibits the growth of leishmanial parasite and pathogenic bacterial strains.
Although RE produces significant analgesia and spasmolytic effects in mice, RE-AgNPs alleviates antispasmodic and analgesic phenomena and hence has clinical potentials for use in humans as such.
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